Lefty A is involved in sunitinib resistance of renal cell carcinoma cells via regulation of IL-8.

Cui, Ning; Han, Qiang; Cao, Qizhen; Wang, Kejun; Zhou, Xujia; Hou, Pingzhi; Liu, Chao; Chen, Lungang; Xu, Lin

Cui, Ning; Han, Qiang; Cao, Qizhen; Wang, Kejun; Zhou, Xujia; Hou, Pingzhi; Liu, Chao; Chen, Lungang; Xu, Lin.

Afiliación

Cui N; Medical Imaging Center, Taihe Hospital, No.32 Renmin South Road, Shiyan 442000, Hubei Province, China.
Han Q; Medical Imaging Center, Taihe Hospital, No.32 Renmin South Road, Shiyan 442000, Hubei Province, China.
Cao Q; Medical Imaging Center, Taihe Hospital, No.32 Renmin South Road, Shiyan 442000, Hubei Province, China.
Wang K; Medical Imaging Center, Taihe Hospital, No.32 Renmin South Road, Shiyan 442000, Hubei Province, China.
Zhou X; Medical Imaging Center, Taihe Hospital, No.32 Renmin South Road, Shiyan 442000, Hubei Province, China.
Hou P; Medical Imaging Center, Taihe Hospital, No.32 Renmin South Road, Shiyan 442000, Hubei Province, China.
Liu C; Medical Imaging Center, Taihe Hospital, No.32 Renmin South Road, Shiyan 442000, Hubei Province, China.
Chen L; Medical Imaging Center, Taihe Hospital, No.32 Renmin South Road, Shiyan 442000, Hubei Province, China.
Xu L; Medical Imaging Center, Taihe Hospital, No.32 Renmin South Road, Shiyan 442000, Hubei Province, China.

Biol Chem ; 402(10): 1247-1256, 2021 09 27.

Article en En | MEDLINE | ID: mdl-34363384

Asunto(s)

Carcinoma de Células Renales; Neoplasias Renales; Sunitinib; Humanos; Interleucina-8/metabolismo

Palabras clave

IL-8; Lefty; RCC; sunitinib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Sunitinib / Neoplasias Renales Límite: Humans Idioma: En Revista: Biol Chem Asunto de la revista: BIOQUIMICA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google